Investors looking to find promising growth chances often face the task of balancing a company's basic financial soundness with its market trend. One technique that tries to combine these two key parts is a strategy that filters for solid growth stocks showing good technical breakout formations. This method tries to find firms with sound basic growth traits, like speeding up earnings and sales, while also finding times where the stock's price movement indicates a possible change in market feeling, often coming before a continued rise. The aim is to find picks where good business results are starting to be seen and shown in the stock's technical picture.
Vericel Corp (NASDAQ:VCEL) is a biotechnology firm centered on advanced treatments for the sports medicine and serious burn care markets. Its product list holds MACI for cartilage repair in the knee and Epicel, a lasting skin replacement for bad burns. As a member in the specific biotech area, its growth is linked to the use of these new, patient-specific cellular treatments.
Basic Growth Review
A core part of this filtering strategy is finding firms with clear and projected growth. As stated by the basic analysis report for VCEL, the firm shows several main positives in this area. The report gives VCEL a Growth Rating of 5 out of 10, pointing to acceptable growth measures compared to its industry group. More notably, the basic data shows a strong growth story:
- Good Past EPS Growth: Vericel's Earnings Per Share has grown by a notable 72.22% over the last year, with a typical yearly EPS growth of 44.04% over many years.
- Sound Future Projections: Experts predict solid forward growth, with EPS expected to rise by 45.18% each year and sales forecast to grow by 19.21% yearly.
- High Profitability Margins: The firm's profitability measures are a positive, often placed in the high end of its biotechnology industry. Its Gross Margin of 73.81%, Operating Margin of 2.75%, and Profit Margin of 5.06% all do better than a large part of its group.
This mix of high past growth rates, good future projections, and high operational margins is exactly the picture a growth investor looks for. It indicates a firm that is not only getting bigger quickly but is doing so in a capable way, changing sales into profit well.
Financial Soundness and Value Setting
For a growth plan to last, the firm must also be on firm financial ground. Vericel gets a very good Health Rating of 7 out of 10. The firm has no debt, which is an uncommon and important plus, removing failure risk and giving financial room. Its cash position is also high, with a Current Ratio of 4.87 and a Quick Ratio of 4.47, showing enough means to meet near-term needs.
On value, the report shows a varied image common of many growth stocks. While VCEL's Price-to-Earnings ratio seems high in plain terms, it is viewed as low priced compared to 88% of its biotechnology industry group. This industry-relative price, mixed with its high expected earnings growth, makes a reason for its current value. The filtering system stresses solid growth and acceptable health, and VCEL's basic report fits with these needs, even as its value needs a view of its high-growth field.
Technical Picture and Breakout Chance
The second leg of this strategy uses technical study to find a good entry point. The technical analysis report for VCEL notes a Setup Rating of 7 out of 10, pointing out a "acceptable setup formation" even with a medium total technical rating. This is a key difference: the stock may not be in a strong long-term upward trend yet, but its recent price movement is coming together in a way that often comes before a new directional move.
The technical view shows the stock trading inside a set band over the last month, having found a floor after a longer time of lower results. Importantly, the report finds a clear resistance area just above the present price, starting at $38.66. The setup indicates that a clear move above this resistance level could mark a technical breakout, possibly pulling new buyer interest. The presence of set support under the present price also allows for clearer risk control. This formation of coming together near resistance is what the filter aims for, looking for stocks where basic strength may be ready to start a technical move to the higher side.
Summary
Vericel Corp shows a case that fits with a mixed growth and trend strategy. Basically, it shows the signs of a solid growth stock: fast recent earnings growth, high profitability margins, and strong future projections, all backed by a debt-free balance sheet. Technically, it is making a coming together formation near a set resistance level, giving a possible breakout setup. For investors using this method, VCEL stands for a pick where basic business trend and a possible change in market price movement seem to be meeting.
Find More Picks: This study of Vericel Corp came from a specific filter for "Solid Growth Stocks with good Technical Setup Ratings." If this strategy fits with your investment method, you can use our stock filter to find other firms that match similar needs.
Disclaimer: This article is for information only and does not make financial advice, a suggestion, or a deal or request to buy or sell any securities. The information given is based on data supplied and should not be the only base for any investment choice. Investing holds risk, including the possible loss of main funds. Always do your own full check and talk with a skilled financial advisor before making any investment choices.
